SAM
TBPH icon

Smartleaf Asset Management’s Theravance Biopharma TBPH Stock Holding History

Smartleaf Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$885 Hold
58
– – ﹤0.01% 3138
2025
Q4 		$1.1K Buy
58
+5
+9% +$83 ﹤0.01% 3147
2025
Q3 		$764 Buy
+53
New +$670 ﹤0.01% 2789
2025
Q2 		– Sell
-53
Closed -$489 – 2959
2025
Q1 		$489 Sell
53
-41
-44% -$382 ﹤0.01% 2701
2024
Q4 		$890 Buy
94
+31
+49% +$282 ﹤0.01% 2693
2024
Q3 		$510 Sell
63
-174
-73% -$1.51K ﹤0.01% 2782
2024
Q2 		$1.97K Buy
+237
New +$2.14K ﹤0.01% 2230

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smartleaf Asset Management's TBPH Position: Q1 2026 in Review

Smartleaf Asset Management held its Theravance Biopharma (TBPH) position steady in Q1 2026 at 58 shares worth $885. The position accounts for ﹤0.01% of the portfolio, ranked #3138.

Smartleaf Asset Management first reported a position in TBPH in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.97K in Q2 2024. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Smartleaf Asset Management held 58 shares of Theravance Biopharma worth $885 as of Q1 2026.
  • Smartleaf Asset Management left its Theravance Biopharma share count unchanged in Q1 2026.
  • Theravance Biopharma made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3138 holding.
  • Smartleaf Asset Management first reported a position in Theravance Biopharma in Q2 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Theravance Biopharma position peaked at $1.97K in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.